Skip to main content
. 2020 Jan 13;2020(1):CD009256. doi: 10.1002/14651858.CD009256.pub3

Comparison 4. Sensitivity analysis (phase III trials).

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Overall survival 4 2210 Hazard Ratio (Random, 95% CI) 0.99 [0.45, 2.17]
2 1‐year survival rate 5 3573 Risk Ratio (M‐H, Random, 95% CI) 0.97 [0.84, 1.13]
3 Response rate 5 3549 Risk Ratio (M‐H, Random, 95% CI) 0.86 [0.71, 1.03]